Suture-securing for cardiac valve repair

Abstract
Apparatus is provided that includes a casing, shaped to define a cavity, and one or more openings in the casing, in which openings one or more sutures are disposable; and a core, disposed in the cavity, and shaped to define a lumen in which the sutures are disposable. The apparatus has an unlocked configuration in which the sutures are disposable within and slidable through the openings and the lumen, and a locking configuration in which the sutures are inhibited from sliding through the openings and the lumen. The apparatus is movable from the unlocked configuration to the locking configuration, and is configured such that, when the sutures are disposed within the openings and the lumen, and the apparatus moves from the unlocked configuration to the locking configuration, the apparatus cuts the sutures at a cutting site, and becomes coupled to the sutures at a coupling site.
Description
FIELD OF THE INVENTION

Some applications of the present invention relate in general to surgical techniques. More specifically, some applications of the present invention relate to techniques for securing sutures. More specifically, some applications of the present invention relate to transluminal techniques for securing sutures.


BACKGROUND

Functional tricuspid regurgitation (FTR) is governed by several pathophysiologic abnormalities such as tricuspid valve annular dilatation, annular shape, pulmonary hypertension, left or right ventricle dysfunction, right ventricle geometry, and leaflet tethering. Treatment options for FTR are primarily surgical. The current prevalence of moderate-to-severe tricuspid regurgitation is estimated to be 1.6 million in the United States. Of these, only 8,000 patients undergo tricuspid valve surgeries annually, most of them in conjunction with left heart valve surgeries.


SUMMARY OF THE INVENTION

In some applications of the invention, apparatus and methods are provided for fixedly coupling sutures to each other. For some such applications, the apparatus comprises a suture-securing device that comprises two tubular elements that are movably coupled to each other. For other such applications, the apparatus comprises a suture-securing device that comprises a casing and a core that are movably coupled to each other. Both suture-securing devices described have an unlocked configuration, in which sutures are generally slidable through the device, and a locking configuration, in which the sutures are generally not slidable through the device.


In some applications of the invention, the suture-securing devices are configured to be biased to moving toward the locking configuration thereof, and are retained in the unlocked configuration by a constraint. For such applications, the devices automatically move toward the locking configuration when the constraint is removed.


In some applications of the invention, techniques are provided for using the suture-securing device to repair a heart valve, by fixedly coupling together sutures that are coupled to different parts of the annulus of the valve.


In some applications of the invention, apparatus and methods are provided for repairing a heart valve by sandwiching valve leaflets between a support and a securing element, such that multiple orifices are formed between respective portions of the valve leaflets. Typically, the support is generally disc-shaped, and comprises a wire-mesh. Typically, the securing element comprises a plurality of arms, one end of each arm coupled to a central core, and the other end of each arm coupled to leaflet-piercing elements, which protrude through the valve leaflets and into the wire mesh of the support.


There is therefore provided, in accordance with an application of the present invention, apparatus for use with a heart valve of a patient, the heart valve including at least two leaflets, the apparatus including:


a support, having a leaflet-engaging side, configured to be placed against a first side of the heart valve in a position in which respective portions of the leaflet-engaging side of the support are disposed against respective regions of respective leaflets of the valve; and


a plurality of leaflet-piercing elements, deliverable to a second side of the heart valve of the patient, and configured to couple the support to the heart valve by (1) piercing the leaflets of the heart valve from the second side of the heart valve to the first side of the heart valve, and (2) coupling to the support while the support is in the position on the first side of the heart valve.


In an application, the support is flat.


In an application, the support is disc-shaped.


In an application, the support has a delivery configuration in which the support is generally cylindrical, and a deployed configuration in which the support is generally flat.


In an application, the support includes a braided wire mesh.


In an application, the leaflet-piercing elements include straight spikes.


In an application, the leaflet-piercing elements include barbs.


In an application, the leaflet-piercing elements include hooks.


In an application, the leaflet-piercing elements are configured to couple to the support by being configured to protrude into the support.


In an application, the leaflet-piercing elements are configured to couple to the support by being configured to protrude through the support.


In an application, the support is transluminally deliverable to the first side of the heart valve of the patient.


In an application, the leaflet-piercing elements are transluminally deliverable to the second side of the heart valve independently of the support.


In an application, the apparatus further includes a securing element, including:


a core;


two or more arms, an inner end of each arm being coupled to the core, and the arms extending radially outward from the core; and


the leaflet-piercing elements, coupled to respective outer ends of each arm.


In an application, the securing element is transluminally deliverable to the second side of the heart valve independently of the support.


In an application, the apparatus is configured such that the leaflet-engaging elements are configured to be coupled to the support by the securing element being configured to be coupled to the support.


In an application, the apparatus is configured such that coupling the leaflet-engaging elements to the support while the support is in the position on the first side of the heart valve, sandwiches the leaflets of the heart valve between the support and the securing element.


In an application, the core defines a coupling portion, configured to couple the core to the support.


In an application, the apparatus is configured such that the coupling of the core to the support facilitates the coupling of the leaflet-piercing elements to the support.


In an application, the support defines an inner perimeter that defines an opening through the support, and the coupling portion is configured to couple the core to the support, by being configured to secure at least part of the coupling portion within the opening.


In an application, the core is configured to extend between the leaflets of the heart valve, from the second side of the heart valve to the first side of the heart valve, such that the coupling portion is couplable to the support at the first side of the heart valve.


In an application, the securing element has a delivery configuration and a deployed configuration, and the outer end of the arms are closer to each other in the delivery configuration than in the deployed configuration.


In an application:


the securing element is disposable within a sheath, and is removable from the sheath,


the delivery configuration defines a constrained configuration, the sheath being configured to constrain the securing element in the constrained delivery configuration,


the deployed configuration defines an unconstrained configuration, and


the securing element is configured to automatically move from the delivery configuration to the deployed configuration when the securing element is removed from the sheath.


There is further provided, in accordance with an application of the present invention, a method for use with a heart valve of a patient, the heart valve including at least two leaflets, the method including:


delivering, to a first side of the heart valve, a support, having a leaflet-engaging side;


delivering, to a second side of the heart valve, a plurality of leaflet-piercing elements;


piercing the leaflets of the valve, from the second side to the first side of the valve, with the leaflet-piercing elements; and


coupling the support to the leaflets, such that respective portions of the leaflet-engaging side of the support are disposed against respective regions of respective leaflets, by coupling, at the first side of the valve, the leaflet-piercing elements to the support.


In an application, delivering the support includes delivering a flat support.


In an application, delivering the support includes delivering a disc-shaped support.


In an application, delivering the support includes delivering a support that includes a braided wire mesh.


In an application, delivering the support includes:


percutaneously delivering the support while the support is in a generally-cylindrical delivery configuration thereof, and


subsequently, deploying the support into a generally flat deployed configuration thereof.


In an application, coupling the leaflet-piercing elements to the support includes advancing the leaflet-piercing elements into the support.


In an application, coupling the leaflet-piercing elements to the support includes advancing the leaflet-piercing elements through the support.


In an application, delivering the leaflet-piercing elements includes delivering the leaflet-piercing elements independently of delivering the support.


In an application, delivering the leaflet-piercing elements includes delivering, to the second side of the valve, a securing element that includes (1) a core, (2) two or more arms, an inner end of each arm being coupled to the core, and the arms extending radially outward from the core, and (3) the leaflet-piercing elements, coupled to respective outer ends of each arm.


In an application, coupling the leaflet-piercing elements to the support includes coupling the securing element to the support.


In an application, coupling the securing element to the support includes sandwiching the leaflets between the securing element and the support.


In an application, coupling the securing element to the support includes coupling the core to the support, and coupling the core to the support facilitates coupling the leaflet-piercing elements to the support.


In an application, the core defines a coupling portion, and coupling the securing element to the support includes coupling the coupling portion of the core to the support.


In an application, coupling the coupling portion to the support facilitates the coupling of the leaflet-piercing elements to the support.


In an application, the support defines an inner perimeter that defines an opening through the support, and coupling the coupling portion of the core to the support includes securing at least part of the coupling portion within the opening.


In an application, coupling the coupling portion of the core to the support, includes coupling the coupling portion to the support at the first side of the heart valve.


In an application, coupling the coupling portion to the support includes moving at least part of the coupling portion, from the second side of the heart valve, between the leaflets of the heart valve, to the first side of the heart valve.


There is further provided, in accordance with an application of the present invention, apparatus for use with one or more sutures, the apparatus including:


a first tubular element, shaped to define a first lumen therethrough, and having a first end and a second end; and


a second tubular element, shaped to define a second lumen therethrough, and having a first end and a second end,


the apparatus having:

    • an unlocked configuration in which:
      • the first end of the second tubular element is disposed closer to the first end of the first tubular element than is the second end of the second tubular element, and
      • the sutures are disposable within and slidable through the first and second lumens, and
    • a locking configuration in which:
      • the second end of the second tubular element is disposed closer to the first end of the first tubular element than is the first end of the second tubular element, and
      • the sutures are inhibited from sliding through the first and second lumens.


In an application, the second tubular element has a length, from the first end of the second tubular element to the second end of the second tubular element, that is smaller than the cross-sectional diameter of the first lumen.


In an application, the sutures include a first suture and a second suture, and the apparatus having a locking configuration in which the sutures are inhibited from sliding through the first and second lumens, includes the apparatus having a locking configuration in which the first suture is inhibited from moving with respect to the second suture.


In an application, the apparatus is configured such that:


in the unlocked configuration, the second end of the second tubular element is disposed outside of the first lumen, and


in the locking configuration, the second end of the second tubular element is disposed within the first lumen.


In an application, the second end of the first tubular element is coupled to the first end of the second tubular element.


In an application, the apparatus is configured such that, when the sutures are disposed within the lumens of the first and second tubular elements, movement of the apparatus from the unlocked to the locking configuration rotates at least a portion of each suture.


In an application, the apparatus is configured such that movement of the apparatus from the unlocked to the locking configuration rotates the second tubular element.


In an application, the first and second tubular elements include a continuous piece of material.


In an application, the first tubular element is shaped such that the first lumen has a cross-sectional diameter that is greater than a cross-sectional diameter of the second lumen.


In an application, the first tubular element is shaped such that the first lumen has a cross-sectional diameter that is more than 1.1 times greater than the cross-sectional diameter of the second lumen.


In an application, the first tubular element is shaped such that the first lumen has a cross-sectional diameter that is less than 1.5 times greater than the cross-sectional diameter of the second lumen.


In an application:


the unlocked configuration includes a constrained configuration, and the locking configuration includes an unconstrained configuration, and


the apparatus is configured to be retained in the constrained unlocked configuration by a constraining force, and to automatically move toward the unconstrained locking configuration when the constraining force is removed.


In an application, the apparatus further includes a constraint, configured to provide the constraining force.


In an application, the constraint includes a rod, disposable in the lumen of at least one of the tubular elements, configured to provide the constraining force by being disposed in the lumen, the constraining force being removable by removing the rod from the lumen.


In an application, the constraint includes a constraining sheath, configured to provide the constraining force by being disposed around at least one of the tubular members, the constraining force being removable by removing the sheath from the at least one of the tubular members.


In an application, the first and second tubular elements both define respective inner and outer surfaces, and, in the locking configuration, at least part of the outer surface of the second tubular element is disposed against at least part of the inner surface of the first tubular element.


In an application, the apparatus is configured such that, when the sutures are disposed within the lumens of the first and second tubular elements, movement of the apparatus from the unlocked to the locking configuration sandwiches at least a portion of each suture between the outer surface of the second tubular element and the inner surface of the first tubular element.


In an application, the apparatus includes at least one helical element.


In an application, at least in the unlocked configuration, the apparatus defines a continuous helix from the first end of the first tubular element to the second end of the second tubular element.


In an application, the first tubular element includes a first helical element and the second tubular element includes a second helical element.


In an application, the second end of the first tubular element is coupled to the first end of the second tubular element by a connecting portion.


In an application, the tubular elements and the connecting portion include a continuous piece of material.


There is further provided, in accordance with an application of the present invention, apparatus for use with one or more sutures, the apparatus including:


a first tubular element, shaped to define a first lumen therethrough, and having a proximal end and a distal end; and


a second tubular element, shaped to define a second lumen therethrough, and having a first end and a second end, the apparatus having:

    • an unlocked configuration in which:
      • the second end of the second tubular element is disposed distally to the first end of the second tubular element, and
      • the sutures are disposable within and slidable through the first and second lumens, and
    • a locking configuration in which:
      • the first end of the second tubular element is disposed distally to the second end of the second tubular element, and
      • the sutures are inhibited from sliding through the first and second lumens.


In an application, the apparatus is configured such that:


in the unlocked configuration, the second end of the second tubular element is disposed outside of the first lumen, and


in the locking configuration, the second end of the second tubular element is disposed within the first lumen.


In an application, the apparatus is configured such that, when the sutures are disposed within the lumens of the first and second tubular elements, movement of the apparatus from the unlocked to the locking configuration rotates at least a portion of each suture.


In an application, the first and second tubular elements both define respective inner and outer surfaces, and, in the locking configuration, at least part of the outer surface of the second tubular element is disposed against at least part of the inner surface of the first tubular element.


In an application, the apparatus is configured such that, when the sutures are disposed within the lumens of the first and second tubular elements, movement of the apparatus from the unlocked to the locking configuration sandwiches at least a portion of each suture between the outer surface of the second tubular element and the inner surface of the first tubular element.


There is further provided, in accordance with an application of the present invention, apparatus for use with one or more sutures, the apparatus including:


a first tubular element, shaped to define a first lumen therethrough; and


a second tubular element, coupled to the first tubular element, and shaped to define a second lumen therethrough,


the apparatus having:

    • an unlocked configuration in which at least a quarter of the second tubular element is disposed outside of the first lumen, and the sutures are disposable within and slidable through the first and second lumens, and
    • a locking configuration in which at least a quarter of the second tubular element is disposed inside the first lumen, and the sutures are inhibited from sliding through the first and second lumens, and


the apparatus being constrainable in the unlocked configuration by a removable constraining force, and configured to automatically move toward the second configuration when the constraining force is removed.


In an application, the apparatus is configured such that, when the sutures are disposed within the lumens of the first and second tubular elements, movement of the apparatus from the unlocked to the locking configuration rotates at least a portion of each suture.


In an application, the first and second tubular elements both define respective inner and outer surfaces, and, in the locking configuration, at least part of the outer surface of the second tubular element is disposed against at least part of the inner surface of the first tubular element.


In an application, the apparatus is configured such that, when the sutures are disposed within the lumens of the first and second tubular elements, movement of the apparatus from the unlocked to the locking configuration sandwiches at least a portion of each suture between the outer surface of the second tubular element and the inner surface of the first tubular element.


There is further provided, in accordance with an application of the present invention, apparatus for use with one or more sutures, the apparatus including:


a first tubular element, shaped to define a first lumen therethrough; and


a second tubular element shaped to define a second lumen therethrough, the second tubular element being coupled to the first tubular element at a coupling point, the coupling point being configured to facilitate deflection of the second tubular element around the coupling point, and


the apparatus:

    • having an unlocked configuration in which the sutures are disposable within and slidable though the first and second lumens, and a locking configuration in which the sutures are inhibited from sliding through the first and second lumens,
    • being configured to be constrainable in the unlocked configuration by a constraining force, and
    • being configured, when the constraining force is removed, to automatically move from the unlocked configuration to the locking configuration, by the second tubular element deflecting around the coupling point.


In an application, the apparatus is configured such that, when the sutures are disposed within the lumens of the first and second tubular elements, the deflecting of the second tubular element around the coupling point rotates at least a portion of each suture.


In an application, the first and second tubular elements both define respective inner and outer surfaces, and, in the locking configuration, at least part of the outer surface of the second tubular element is disposed against at least part of the inner surface of the first tubular element.


In an application, the apparatus is configured such that, when the sutures are disposed within the lumens of the first and second tubular elements, the deflecting of the second tubular element around the coupling point sandwiches at least a portion of each suture between the outer surface of the second tubular element and the inner surface of the first tubular element.


There is further provided, in accordance with an application of the present invention, apparatus for use with one or more sutures, the apparatus including:


a casing, shaped to define a cavity, and one or more openings in which the sutures are disposable;


a core, disposed in the cavity, and shaped to define a lumen in which the sutures are disposable,


the apparatus:

    • having an unlocked configuration in which the sutures are disposable within and slidable through the openings and the lumen, and a locking configuration in which the sutures are inhibited from sliding through the openings and the lumen,
    • being movable from the unlocked configuration to the locking configuration, and
    • being configured such that, when the sutures are disposed within the openings and the lumen, and the apparatus moves from the unlocked configuration to the locking configuration, the apparatus (1) cuts the sutures at a cutting site of the apparatus, and (2) becomes coupled to the sutures at a coupling site of the apparatus.


In an application:


the casing defines two or more openings, the openings being provided along a longitudinal axis of the casing,


in the unlocked configuration of the apparatus, the lumen of the core is disposed along the axis, and between the openings, and


in the locking configuration of the apparatus, the core is disposed with respect to the casing in a manner in which the lumen of the core is not disposed along the axis.


In an application:


the casing defines two or more openings,


in the unlocked configuration of the apparatus, the lumen of the core is generally in fluid communication with the openings, and


in the locking configuration of the apparatus, the lumen of the core is generally not in fluid communication with the openings.


In an application:


the unlocked configuration includes a constrained configuration, and the locking configuration includes an unconstrained configuration, and


the apparatus is configured to be retained in the constrained unlocked configuration by a constraining force, and to automatically move toward the unconstrained locking configuration when the constraining force is removed.


In an application, the apparatus further includes a constraint, configured to provide the constraining force.


In an application, the constraint includes a constraining sheath.


In an application, the cutting site includes at least one cutting edge, and the apparatus is configured to cut the sutures by pushing the sutures against the cutting edge.


In an application:


the at least one cutting edge includes first and second cutting edges,


the casing is shaped to define the first cutting edge, and


the core is shaped to define the second cutting edge. 83. A method for use with one or more sutures at an anatomical site of a patient, the method including:


delivering, to a vicinity of the anatomical site, apparatus that includes (1) a first tubular element, shaped to define a first lumen therethrough, and having a first end and a second end, and (2) a second tubular element, shaped to define a second lumen therethrough, and having a first end and a second end;


sliding the apparatus over at least part of the sutures while the apparatus is in an unlocked configuration thereof in which (1) the first end of the second tubular element is disposed closer to the first end of the first tubular element than is the second end of the second tubular element, and (2) the sutures are slidable through the first and second lumens; and


securing the apparatus to the sutures by moving the apparatus into a locking configuration thereof in which: (1) the second end of the second tubular element is disposed closer to the first end of the first tubular element than is the first end of the second tubular element, and (2) the sutures are inhibited from sliding through the first and second lumens.


There is further provided, in accordance with an application of the present invention, a method for use with one or more sutures at an anatomical site of a patient, the method including:


delivering, to a vicinity of the anatomical site, apparatus that includes (1) a first tubular element, shaped to define a first lumen therethrough, and having a first end and a second end, and (2) a second tubular element, shaped to define a second lumen therethrough, and having a first end and a second end;


sliding the apparatus over at least part of the sutures while the apparatus is in an unlocked configuration thereof in which (1) the first end of the second tubular element is disposed closer to the first end of the first tubular element than is the second end of the second tubular element, and (2) the sutures are slidable through the first and second lumens;


and subsequently inhibiting the sutures from sliding through the first and second lumens by moving the apparatus into a locking configuration in which the second end of the second tubular element is disposed closer to the first end of the first tubular element than is the first end of the second tubular element.


In an application, in the unlocked configuration, the second end of the second tubular element of the apparatus is disposed outside of the first lumen, and moving the apparatus into the locking configuration includes moving the second end of the second tubular element into the first lumen.


In an application, moving the apparatus into the locking configuration includes moving at least a quarter of the second tubular element into the first lumen.


In an application, moving the apparatus into the locking configuration includes sandwiching at least a portion of each suture between an outer surface of the second tubular element and an inner surface of the first tubular element.


In an application, the apparatus is configured to be constrained in the unlocked configuration by a constraining force, and moving the apparatus into the locking configuration includes removing the constraining force.


In an application, removing the constraining force includes removing, from the lumen of at least one of the tubular elements, a rod that is (1) disposed in the lumen of the least one of the tubular elements, and (2) configured to provide the constraining force.


In an application, removing the constraining force includes removing, from around at least one of the tubular elements, a constraining sheath that is (1) disposed around the at least one of the tubular elements, and (2) configured to provide the constraining force.


In an application, moving the apparatus into the locking configuration includes rotating the second tubular element.


In an application, the first tubular element is coupled to the second tubular element via a coupling point, and rotating the second tubular element includes deflecting the second tubular element around the coupling point.


There is further provided, in accordance with an application of the present invention, a method for use with one or more sutures at an anatomical site of a patient, the method including:


delivering, to a vicinity of the anatomical site, apparatus that includes (1) a casing, shaped to define a cavity, and one or more openings in which the sutures are disposable, and (2) a core, disposed in the cavity, and shaped to define a lumen in which the sutures are disposable;


sliding the apparatus over at least part of the sutures while the apparatus is in an unlocked configuration thereof, in which the sutures are slidable through the openings and the lumen; and


subsequently, by moving the apparatus into a locking configuration thereof, simultaneously (1) inhibiting the sutures from sliding through the lumen by coupling the apparatus to the sutures at a coupling site of the apparatus, and (2) cutting the sutures with one or more cutting edges at a cutting site of the apparatus.


In an application, the apparatus is configured to be constrained in the unlocked configuration by a constraining force, and moving the apparatus into the locking configuration includes removing the constraining force.


In an application, removing the constraining force includes removing, from around at least part of the core, a constraining sheath that is (1) disposed around the at least part of the core, and (2) configured to provide the constraining force.


For some applications, techniques described herein are practiced in combination with techniques described in one or more of the references cited in the Background section and Cross-references section of the present patent application.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-B and 2A-B are schematic illustrations of apparatus comprising a suture-securing device, in accordance with some applications of the invention;



FIGS. 3-7 are schematic illustrations of steps in the use of the apparatus of FIGS. 1A-B and 2A-B to repair a cardiac valve, in accordance with some applications of the invention;



FIGS. 8A-B and 9A-B are schematic illustrations of a suture-securing device, in accordance with some applications of the invention;



FIG. 10 is a schematic illustration of the suture-securing device of FIGS. 8A-B and 9A-B, having been used to repair a cardiac valve, in accordance with some applications of the invention;



FIGS. 11A-B are schematic illustrations of apparatus for repairing a heart valve, in accordance with some applications of the invention;



FIGS. 12A-F, 13A-B and 14 are schematic illustrations of the use of the apparatus of FIGS. 11A-B to repair a heart valve, in accordance with some applications of the invention; and



FIG. 15 is a schematic illustration of the apparatus of FIGS. 11A-B having been used to repair a heart valve, in accordance with some applications of the invention.





DETAILED DESCRIPTION OF EMBODIMENTS

Reference is made to FIGS. 1A-B and 2A-B, which are schematic illustrations of apparatus 20, comprising a suture-securing device 22, in accordance with some applications of the invention. Device 22 has an unlocked configuration in which one or more sutures are generally slidable through the device, and a locking configuration in which the sutures are generally not slidable through the device, and is movable from the unlocked configuration to the locking configuration.



FIGS. 1A-B show device 22 in the unlocked configuration thereof. FIG. 1A shows a side view of device 22 being used with two sutures 34a and 34b, and FIG. 1B shows a cutaway view of the same. It is to be noted that, although device 22 is shown being used with two individual sutures, the device may be used with two portions of the same suture (e.g., the suture is looped), and/or with more or fewer sutures (e.g., to secure the device and/or an element coupled thereto, to a particular point on a single suture). It is to be further noted that, although sutures 34a and 34b are shown as ribbon-like sutures (e.g., having a generally rectangular cross-section), any suitable type of suture, as is known in the art, may be used.


Device 22 comprises a first tubular element 24, which is shaped to define a first lumen L1, a first end 10 and a second end 11, and a second tubular element 26, which is shaped to define a second lumen, a first end 12 and a second end 13. Typically, second tubular element 26 is narrower than first tubular element 24. That is, lumen L2 typically has a smaller transverse cross-sectional area than does lumen L1. Typically, the second tubular element has an outer edge that has a diameter D2 that is smaller than a diameter D1 of an inner edge of the first tubular element.


For some applications of the invention, diameter D1 is more than 1.1 times greater and/or less than 1.5 times greater than diameter D2. Typically, second tubular element 26 has a longitudinal length (i.e., from first end 12 to second end 13) that is smaller than diameter D1 of first tubular element 24, e.g., so as to facilitate rotation of the second tubular element within lumen L1 of the first tubular element.


Typically, device 22 is used in catheter-based procedures or minimally-invasive procedures, and is positioned with respect to the operating physician such that second tubular element 26 is distal to first tubular element 24. Alternatively, the device is positioned with respect to the physician such that the first tubular element is distal to the second tubular element. For some applications, device 22 may be used in a surgical procedure, e.g., an open-heart procedure.


In the unlocked configuration of device 22, the first and second tubular elements are typically disposed end to end. That is, in the unlocked configuration of device 22, one or more of the following are typically true:


(1) first end 12 of the second tubular element is disposed closer to first end 10 of the first tubular element than is second end 13 of the second tubular element,


(2) second end 13 of the second tubular element is disposed distally (i.e., with respect to the operating physician) to first end 12 of the second tubular element, and


(3) at least a quarter (e.g., all) of second tubular element 26 is disposed outside of lumen L1 of the first tubular element.


In the unlocked configuration, sutures 34a and 34b are slidable through device 22, i.e., through lumens L1 and L2 of tubular elements 24 and 26. That is, in the unlocked configuration, the device is slidably coupled to the sutures, i.e., is slidable over the sutures. Typically, device 22 is delivered to an anatomical site (e.g., in a vicinity of a site being treated) with sutures 34a and 34b pre-threaded through the device.


Typically, and as shown in FIGS. 1A-B, device 22 comprises at least one helical element, e.g., a coil. For example, and as shown in FIGS. 1A-B, tubular elements 24 and 26 may be defined by at least one helix. Further typically, device 22 comprises a continuous piece of material. For example, device 22 may be fabricated from a single elongate piece of material, such as a wire, that has been shaped to define tubular elements 24 and 26 (e.g., by being shaped to define a first helix that defines tubular element 24, and a second helix that defines tubular element 26). Typically, the material comprises a metal such as, but not limited to, stainless steel, titanium, nickel titanium (Nitinol), nickel cobalt, and/or cobalt chrome. For some applications, the material comprises a polymer and/or a resin. Further typically, and as described hereinbelow with reference to FIGS. 2A-B, the material comprises a shape-memory material.


Helical elements 24 and 26 are typically coupled by a connecting portion 38, which facilitates movement of device 22 from the unlocked configuration to the locking configuration. For some applications in which tubular elements 24 and 26 are defined by helices and comprise a single piece of material, connecting portion 38 also comprises the single piece of material. That is, for such applications, device 22, comprising connecting portion 38, comprises a single piece of material.



FIGS. 2A-B show device 22 in the locking configuration thereof, i.e., after having moved into the locking configuration. FIG. 2A shows a side view of device 22 being used with two sutures 34a and 34b, and FIG. 2B shows a cutaway view of the same. In the locking configuration of device 22, second tubular element 26 is oriented at about 180 degrees compared to its position in the unlocked configuration of the device. That is, when device 22 moved from the unlocked to the locking configuration, the second tubular element rotates and/or is deflected around an axis that is generally orthogonal to a longitudinal axis from first end 10 of the first tubular element to second end 13 of the second tubular element. Typically, and as shown in FIGS. 2A-B, second tubular element 26 is deflected around connecting portion 38.


Typically, in the locking configuration of device 22, one or more of the following are true:


(1) second end 13 of the second tubular element is disposed closer to first end 10 of the first tubular element than is first end 12 of the second tubular element,


(2) first end 12 of the second tubular element is disposed distally (i.e., with respect to the operating physician) to second end 13 of the second tubular element, and


(3) at least a quarter of second tubular element 26 is disposed inside lumen L1 of the first tubular element.


In the locking configuration, sutures 34a and 34b are generally not slidable through device 22, i.e., through lumens L1 and L2 of tubular elements 24 and 26. That is, in the locking configuration, the device is fixedly coupled to the sutures, i.e., is generally not slidable over the sutures. Typically, the device is fixedly coupled to the sutures by sandwiching at least part of the sutures between the two tubular elements, e.g., between the outer edge of second tubular element 26 and the inner edge first tubular element 24, as shown at coupling zone 31 in FIG. 2B.


As described hereinabove, device 22 (i.e., the tubular elements and coupling portion thereof) typically comprises a single piece of material that has been fabricated into at least one helix. Typically, device 22 comprises a shape-memory material, which is configured to be biased (e.g., is shape-set) such that the device moves toward the locking configuration thereof. For such applications, the device is retained in the unlocked configuration by at least one constraint 28 (see FIGS. 1A-B), which provides a constraining force. That is, the locking configuration is an unconstrained locking configuration, and the unlocked configuration is a constrained unlocked configuration.


For some applications, and as shown in FIGS. 1A-B, the constraint comprises a rod 30, and the constraining force is provided by the distal end of the rod being disposed in lumen L2 of second tubular element 26. So as to move device 22 into the locking configuration (e.g., so as to fixedly couple the device to the sutures), the surgeon removes the constraining force, e.g., by removing the constraint, such as by withdrawing rod 30 from at least lumen L2, such that the device automatically moves to the locking configuration.


For applications of the invention in which device 22 is constrained in the unlocked configuration by rod 30, rod 30 is typically shaped to define a lumen, and the sutures are slidable through the device by being slidable through the lumen of the rod.


For some applications, device 22 is constrained in the unlocked configuration by a constraining sheath (not shown) for delivery to an intracorporeal site. At, or in the vicinity of, the intracorporeal site, the device is exposed from the delivery sheath and automatically moves into the locking configuration.


Reference is made to FIGS. 3-7, which are schematic illustrations showing the use of apparatus 20 to treat a condition (e.g., regurgitation or leaflet prolapse) of a cardiac valve 4 of a heart 2 of a patient, in accordance with some applications of the invention. FIGS. 3-7 show valve 4, comprising a tricuspid valve 94, being treated via an inferior vena cava 3 of the patient (e.g., transfemorally). However, the scope of the invention includes the treatment of other heart valves and the use of other access routes, mutatis mutandis. In brief (1) distal ends of sutures 34a and 34b are coupled to two sites on annulus 5 of valve 4, (2) the sutures are placed under tension with respect to each other so as to draw the sites on the annulus toward each other, (3) apparatus is used to secure the sutures in the under-tension configuration, and (4) the sutures are cut and released, so as to leave the sutures under tension and the valve in the drawn-together configuration.



FIG. 3 shows a catheter 46 having been advanced through the inferior vena cava and into the right atrium 7 of the heart of the patient. Via catheter 46, a first helical anchor 40a, coupled to a distal end of suture 34a is coupled to (i.e., screwed into) a first site 6 on annulus 5. Typically, anchor 40a is delivered via a first inner sheath 44a.


Subsequently, and as shown in FIG. 4, a second helical anchor 40b, coupled to a distal end of suture 34b is coupled to a second site 8 on annulus 5. Typically, second site 8 is at least 1 cm from first site 6, such as a quarter of the way around annulus 5 from the first site, such as on the opposite side of the annulus to the first site.


For some applications in which cardiac valve 4 comprises tricuspid valve 94, first site 6 is typically in a vicinity of an anterior-posterior commissure (APC) 88 (i.e., the commissure between anterior leaflet 82 and posterior leaflet 84) of the valve, and second site 8 is in a vicinity of the septal leaflet of the valve.


Typically, anchor 40b is delivered via a second inner sheath 44b. Alternatively, anchors 40a and 40b are delivered via the same inner sheath.



FIG. 5 shows apparatus 20, comprising suture-securing device 22, having been advanced through catheter 46. For some applications, and as shown in FIG. 5, device 22 is delivered via an outer sheath 48. Device 22 is typically delivered in the unlocked configuration thereof, and is typically constrained in the unlocked configuration by rod 30, as described hereinabove. Rod 30 and device 22 are slid over at least part of sutures 34a and 34b. For example, the sutures and helical anchors may be delivered via the lumen of rod 30 (e.g., inner sheaths 44a and 44b may be advanced through the lumen of rod 30).



FIG. 6 shows sutures 34a and 34b having been placed under tension at least with respect to each other, e.g., by pulling respective proximal ends of the sutures proximally and/or by pushing device 22 distally, such as by using a controller 50. The tension draws together anchors 40a and 40b, and thereby draws together sites 6 and 8. Thereby, the annulus of valve 4 is reshaped, so as to treat valve prolapse. This reshaping is typically monitored in real-time (e.g., using ultrasound techniques) so that the operating physician may determine when acceptable reshaping has been achieved.


Reference is now made to FIG. 7. Once the operating physician determines that acceptable reshaping has been achieved, device 22 is moved into the locking configuration, e.g., by withdrawing rod 30 proximally. Typically, sutures 34a and 34b are subsequently released, e.g., by being cut at a proximal side of device 22. Rod 30 and the sheaths and catheter are subsequently removed from the body of the patient.


Reference is made to FIGS. 8A-B and 9A-B, which are schematic illustrations of a suture-securing device 60, in accordance with some applications of the invention. Device 60 has an unlocked configuration in which one or more sutures are generally slidable through the device, and a locking configuration in which the sutures are generally not slidable through the device, and is movable from the unlocked configuration to the locking configuration.



FIGS. 8A-B show device 60 in the unlocked configuration thereof. FIG. 8A shows a perspective view of device 60 being used with two sutures 34a and 34b, and FIG. 8B shows a cutaway view of the same. FIG. 8A further shows an exploded view of device 60. It is to be noted that, although device 60 is shown being used with two individual sutures, the device may be used with two portions of the same suture (e.g., the suture is looped), and/or with more or fewer sutures (e.g., to secure the device and/or an element coupled thereto, to a particular point on a single suture).


Device 60 comprises a casing 62, shaped to define a cavity 63 and one or more openings 64, and a core 66, disposed in cavity 63, and shaped to define a lumen L3 therethrough. Typically, casing 62 defines two openings 64. Typically, cavity 63 is open at a lateral side of the casing. Core 66 is movable, at least in part, within cavity 63. Typically, a pin 70 is disposed through casing 62 and core 66, such that core 66 is movable within cavity 63 without decoupling from casing 62. For example, and as shown in FIGS. 8A-9B, core 66 may be shaped to define a socket 74 that has a transverse cross-sectional shape that is larger than a transverse cross-sectional shape of pin 70. Pin 70 is fixedly coupled to casing 62 and movably-coupled, via socket 74, to core 66. Due to the difference in size between the respective cross-sectional shapes of pin 70 and socket 74, core 66 is movable within cavity 63 without decoupling from casing 62.


In the unlocked configuration of device 60, lumen L3 is typically aligned between openings 64, i.e., the lumen is typically disposed on an axis between the openings. Typically, thereby, in the unlocked configuration, lumen L3 is generally in fluid communication with openings 64.


In the unlocked configuration, sutures 34a and 34b are slidable through device 60, i.e., through openings 64 and lumen L3. That is, in the unlocked configuration, the device is slidably coupled to the sutures, i.e., is slidable over the sutures. Typically, device 60 is delivered to an anatomical site (e.g., in a vicinity of a site being treated) with sutures 34a and 34b pre-threaded through the device.


Device 60 typically further comprises and/or defines one or more cutting edges, such as cutting edges 80a and 80b, described further with reference to FIGS. 9A-B.



FIGS. 9A-B show device 60 in the locking configuration thereof, i.e., after having moved into the locking configuration. FIG. 9A shows a perspective view of device 60 being used with two sutures 34a and 34b, and FIG. 9B shows a cutaway view of the same. In the locking configuration of device 60, lumen L3 is typically not aligned between openings 64, i.e., the lumen is typically not disposed on an axis between the openings. Typically, thereby, in the locking configuration, lumen L3 is generally not in fluid communication with openings 64.


In the locking configuration, sutures 34a and 34b are generally not slidable through device 60, i.e., through openings 64 and lumen L3. That is, in the locking configuration, the device is fixedly coupled to the sutures, i.e., is generally not slidable over the sutures. Typically, the device is fixedly coupled to the sutures by sandwiching at least part of the sutures between core 66 and casing 62, as shown at coupling zone 61 in FIG. 9B.


When device 60 moves into the locking configuration, the device cuts the sutures disposed therein, at a cutting zone 65. Typically, a first cutting edge 80a is defined by casing 62, a second cutting edge 80b is defined by core 66, and when sutures 34a and 34b are slid through device 60, part of each suture is disposed between the two cutting edges. When device 60 moves into the locking configuration, the two cutting edges move toward and, typically, past each other, thereby cutting the sutures.


A portion of each suture typically remains within device 60 subsequent to the fixed-coupling of the device to the sutures. For example, and as shown in FIG. 9B, coupling zone 61 may be disposed close to one end of device 60 (e.g., in a vicinity of one opening 64), and cutting zone 65 may be disposed close to another end of the device (e.g., in a vicinity of the other opening 64).


Device 60 is typically configured to be biased such that the device moves toward the locking configuration thereof. Typically, device 60 is thus configured by comprising at least one spring 72, which moves core 66 with respect to casing 62. For such applications, the device is retained in the unlocked configuration by at least one constraint, which provides a constraining force. That is, the locking configuration is an unconstrained locking configuration, and the unlocked configuration is a constrained unlocked configuration.


For example, a portion of core 66 may protrude from a lateral surface of casing 62 when the device is in the locking configuration, and the constraint may comprise a delivery sheath (not shown), which inhibits that portion of core 66 from protruding thus. So as to move device 60 into the locking configuration (e.g., so as to fixedly couple the device to the sutures, and to cut the sutures), the operating physician removes the constraining force, e.g., by removing the constraint, such as by withdrawing the sheath, such that the device automatically moves to the locking configuration.


Reference is made to FIG. 10, which is a schematic illustration showing device 60 having been used to treat prolapse in cardiac valve 4, in accordance with some applications of the invention. Typically, device 60 is used in combination with the techniques described with reference to FIGS. 3-7, mutatis mutandis. FIG. 10 shows sutures 34a and 34b having been (1) coupled to annulus 5 at sites 6 and 8, using helical anchors 40a and 40b, (2) fixedly coupled to apparatus 60 and, thereby to each other, and (3) cut using apparatus 60.


Reference is made to FIGS. 11A-14, which are schematic illustrations of a system 100 for repairing heart valve 4, and steps in the use of the system for repairing the heart valve, in accordance with some applications of the invention. System 100 comprises a support 102 and a plurality of leaflet-piercing elements 106, configured to couple the support to the heart valve by piercing the leaflets of the heart valve and coupling to the support. Typically, leaflet-piercing elements 106 are deliverable to the valve independently of support 102.


Typically, system 100 comprises a securing element 104, which comprises elements 106. Securing element 104 typically further comprises a core 108 and a plurality of arms 110. A respective inner end of each arm 110 is coupled to core 108, from which the arms extend radially. Elements 106 are coupled to respective outer ends of each arm. Typically, securing element 104 is deliverable to the valve independently of support 102.


Coupling of securing element 104 to support 102 is facilitated by leaflet-piercing elements 106. Typically, support 102 has an inner perimeter 114 that defines an opening 115, and coupling of securing element 104 to support 102 is further facilitated by at least part of core 108 of element 104 being disposed within opening 115. Typically, core 108 is shaped to define a coupling portion 109, which secures the core within the opening. For example, coupling portion 109 may comprise, or be shaped to define, a ridge 111 which inhibits the core from being decoupled from opening 115 (e.g., coupling portion 109 locks core 108 to support 102).



FIG. 11A shows support 102 and securing element 104 individually, and FIG. 11B shows the securing element coupled to the support.


Typically, support 102 comprises a braided wire mesh, which, when unconstrained, has an expanded configuration, and can be compressed into a compressed configuration. Typically, support 102 is compressed into the compressed configuration for delivery to the heart valve, is constrained in the compressed configuration by a catheter via which the support is delivered, and automatically expands upon being released from a distal end of the catheter at the heart valve. Typically, in the compressed configuration, the support is generally cylindrical in shape. In the uncompressed configuration, support 102 defines a leaflet-engaging side 118 (typically a downstream side of the support) that is typically a flat side. In the uncompressed configuration, support 102 itself is typically flat. Further typically, in the uncompressed configuration, the support defines two adjacent layers and is generally circular (i.e., disc-shaped).


Typically, securing element 104 has a delivery configuration in which arms 110 are disposed distally to core 108, and is configured to be movable to a deployed configuration following delivery to the heart valve. Typically, element 104 is configured to be constrained in the delivery configuration by a delivery sheath, and to automatically move toward the deployed configuration upon being exposed from the sheath at the heart valve.



FIGS. 11A-14 show apparatus 100, and its use in treating tricuspid valve 94 via inferior vena cava 3 of the patient. However, the scope of the invention includes the treatment of other heart valves and the use of other access routes, mutatis mutandis. Additionally, securing element 104 is shown comprising 6 arms and leaflet-piercing elements, but may comprise other pluralities of arms and leaflet-piercing elements.



FIGS. 12A-F show steps in the use of apparatus 100 to treat (e.g., to repair) valve 4, in accordance with some applications of the invention. A catheter 120 is advanced to the valve; typically to right atrium 7 via inferior pulmonary artery 3 (e.g., transfemorally), as shown in FIG. 12A. FIG. 12B shows a delivery sheath 122 having been advanced out of a distal end of catheter 120 and, via valve 4, to a downstream side of the valve (i.e., into right ventricle 9) of the patient. FIG. 12B further shows securing element 104 having been moved (e.g., advanced distally) out of delivery sheath 122 and into ventricle 9, and expanding into the deployed configuration.


Subsequently, securing element 104 is moved (e.g., pulled) proximally, such that leaflet-piercing elements 106 pierce the leaflets of the valve, thereby coupling the securing element to the leaflets, as shown in FIG. 12C. Securing element 104 is shown comprising six arms and leaflet-piercing elements, and being coupled to the leaflets such that two leaflet-piercing elements pierce (i.e., couple to) each leaflet. It is to be noted that the scope of the present invention includes securing element 104 comprising other pluralities of arms and/or leaflet-piercing elements, and other configurations of coupling to the leaflets.


Subsequently, as shown in FIG. 12D-E, support 102 is delivered to an upstream side of the valve (i.e., into right atrium 7). Typically, support 102 is advanced through catheter 120 and, upon being exposed from the end of the catheter, automatically expands into its expanded configuration. Typically, delivery sheath 122 is typically disposed within opening 115 of the support. That is, perimeter 114 of the support is disposed around delivery sheath 122, which is typically still coupled to securing element 104. For some applications, delivery sheath 122 is coupled to securing element 104 by a lock 124 (see FIG. 13A), which is controllable from outside of the body of the patient. For some such applications, lock 124 is directly coupled to delivery sheath 122. Alternatively, lock 124 is coupled to a controller (e.g., a control wire; not shown) that is disposed within sheath 122.


Support 102 is placed against the leaflets of the valve (e.g., leaflet-engaging side 118 of the support is placed against the upstream surface of the leaflets), typically by being slid over delivery sheath 122. That is, delivery sheath 122 typically acts as a guide for support 102. FIG. 12E shows a perspective view, and FIG. 13A shows a respective cutaway view, of support 102 disposed against the leaflets. Typically, support 102 is placed, and is configured to be placed, against the leaflets of the valve such that the support overlaps more than one leaflet. That is, the support is typically placed such that respective portions of the leaflet-engaging side of the support are disposed against respective regions of respective leaflets of the valve.



FIGS. 12F and 13B show respective perspective and cutaway views of support 102 having been fixedly coupled to securing element 104, thereby sandwiching the leaflets of the valve between the support and the securing element. Leaflet-piercing elements 106 typically protrude into (e.g., through) support 102. FIGS. 12F and 13B also show catheter 120 and sheath 122 having been removed from the body of the patient. Typically, this fixed coupling is performed by securing element 104 is held immobile or pulled proximally, while support 102 is pushed distally, such that inner perimeter 114 of the support is slid over at least part of core 108 of the coupling element. For example, the support may be slid over coupling portion 109, such that ridge 111 is ‘clicked’ into place. Typically, support 102 is pushed distally using catheter 120 and/or a separate controller (not shown). If support 102 is pushed using catheter 120, the catheter has an outer diameter that is greater than the diameter of opening 115 of the support.



FIG. 13B shows arms 110 of securing element 104 as being bent compared to the appearance of the arms in FIG. 13A. For some applications of the invention, arms 110 are resilient, and are configured to be bent by the coupling of element 104 to support 102, acting like a spring. This configuration facilitates the coupling of apparatus 100 to the valve leaflets by transferring force from the coupling of coupling portion 109 and perimeter 114, to leaflet-piercing elements 106, thereby holding leaflet-piercing elements 106 within the leaflets and within mesh 112 of support 102. That is, coupling of coupling portion 109 of core 108 to the support facilitates coupling of the leaflet-piercing elements to the support. For some applications of the invention, leaflet-piercing elements 106 comprise straight spikes. For other applications of the invention, leaflet-piercing elements 106 comprise barbs or hooks, so as to facilitate fixed coupling of the leaflet-piercing elements directly to mesh 112.


As shown in FIGS. 12F and 13B, when apparatus 100 is implanted (i.e., coupled to the leaflets of the heart valve), arms 110 of securing element 104 are typically disposed on one side of the valve, and both coupling portion 109 and leaflet-piercing elements 106 are coupled to support 102 on the other side of the valve. Thereby, for some applications, securing element 104 is coupled to support 102 only at the upstream side of the heart valve of the patient.



FIGS. 12A-13B show securing element 104 being moved proximally (i.e., upstream), so as to couple to the valve leaflets, prior to the delivery of support 102. However, for some applications of the invention, support 102 is delivered before moving element 104 proximally.



FIG. 14 is an atrial-side view of apparatus 100 having been used to repair valve 4 (e.g., tricuspid valve 94), as described in FIGS. 12A-13B. Support 102 is typically coupled to the leaflets of the valve such that the support overlaps more than one leaflet. That is, the support is typically coupled to the valve such that respective regions of the support are disposed against respective portions of respective leaflets of the valve. The cusps of the leaflets of the valve are typically held close to each other (e.g., touching each other) by apparatus 100, which is thereby disposed generally centrally in the valve. Typically, portions of the leaflets between apparatus 100 and the leaflet commissures (e.g., APC 88) are not held close to each other, and move with the beating of the heart. That is, these portions of the leaflets typically open during ventricular diastole and close during ventricular systole, thereby forming three orifices which typically act as separate valves. FIG. 14 shows these portions of the leaflets open (i.e., during diastole), such that right ventricle 9 is visible therebetween.


For some applications of the invention, support 102 is dimensioned to cover more than 10% and/or less than 90% (e.g., between 10% and 90%, such as between 10% and 30%) of the area defined by the native orifice of the heart valve. For example, a support of desired dimensions may be selected according to the valve and/or patient being treated (e.g., following measurement of the valve being treated).


It is hypothesized that the use of apparatus 100 as described with reference to FIGS. 11-14 reduces heart valve regurgitation, and may be used to repair a diseased heart valve.


Reference is now made to FIG. 15. Although apparatus 100 is shown hereinabove being configured and used, to repair tricuspid valve 94, the apparatus may be configured and used with other heart valves. For example, FIG. 15 shows apparatus 100 having been used to repair a mitral valve 130 of a patient, whereby support 102 is disposed in a right atrium 137 of the patient, and securing element 104 (not visible in FIG. 15) is disposed in a right ventricle 139 of the patient. For a bicuspid heart valve such as mitral valve 130, two orifices are typically formed between apparatus 100 and the commissures.


Apparatus 100 is typically coupled to the heart valve being treated, such that support 102 is disposed against an upstream side of the valve (i.e., an upstream side of the valve leaflets), and securing element 104 is disposed against a downstream side of the valve (i.e., against a downstream side of the valve leaflets). However, for some applications, apparatus 100 is coupled to the heart valve such that support 102 is disposed against the downstream side of the valve, and securing element 104 is disposed against the upstream side of the valve.


Apparatus 100 is typically delivered to the heart valve percutaneously (e.g., transcatheterally and/or transluminally). Apparatus 100 is shown being delivered transluminally from an upstream side of the valve (e.g., via the inferior vena cava). That is, typically, from the perspective of the operating physician, the upstream side of the valve is the proximal side of the valve, and the downstream side of the valve is the distal side of the valve. However, it is to be noted that the scope of the present invention includes delivery from a downstream side of the valve (e.g., transapically, or via the aorta), mutatis mutandis.


Reference is now made to FIGS. 8A-15. Typically, device (FIGS. 8A-10) and system 100 (9A-15) are used in catheter-based procedures or minimally-invasive procedures. For some applications, device 60 (FIGS. 8A-10) and system 100 (9A-15) may be used in a surgical procedure, e.g., an open-heart procedure.


Reference is made to FIGS. 1A-15. It is to be noted that devices 22 and 60, and system 100 described herein may be used in any suitable location in the body of the patient. For example, devices 22 and 60 can be used to secure sutures in any part of the body. Additionally, it is to be noted that devices 22 and 60, and system 100 described herein may be used in any cardiac valve (i.e., the mitral, the tricuspid, the pulmonary, and the aortic valve) of the patient.


It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims
  • 1. Apparatus for use with one or more sutures, the apparatus comprising a suture-securing device, which comprises: a casing, which is shaped to define a first cutting edge, a cavity, and two openings in the casing at opposite ends of the casing, wherein the one or more sutures are disposable through the two openings; anda core, which is (a) disposed in the cavity, and (b) shaped to define a second cutting edge and a lumen, wherein the one or more sutures are disposable in the lumen,wherein the suture-securing device is configured:(i) to have an unlocked configuration in which the one or more sutures are disposable within and slidable through the two openings and the lumen, and a locking configuration in which the one or more sutures are inhibited from sliding through the two openings and the lumen,(ii) to be movable from the unlocked configuration to the locking configuration, such that, when the one or more sutures are disposed within the two openings and the lumen, and the suture-securing device moves from the unlocked configuration to the locking configuration, the suture-securing device (1) cuts entirely through the one or more sutures at a cutting site of the suture-securing device by pushing the one or more sutures against the first and the second cutting edges, and (2) becomes fixedly coupled to the one or more sutures at a coupling site of the suture-securing device, and(iii) to be suspended along the one or more sutures in the locking configuration with the opposite ends of the casing disposed entirely within a body of a patient.
  • 2. The apparatus according to claim 1, wherein the two openings are provided along a longitudinal axis of the casing,wherein in the unlocked configuration of the suture-securing device, the lumen of the core is disposed along the axis, and between the two openings, andwherein in the locking configuration of the suture-securing device, the core is disposed with respect to the casing in a manner in which the lumen of the core is not disposed along the axis.
  • 3. The apparatus according to claim 1, wherein the unlocked configuration comprises a constrained configuration, and the locking configuration comprises an unconstrained configuration, andwherein the suture-securing device is configured to be retained in the constrained unlocked configuration by a constraining force, and to automatically move toward the unconstrained locking configuration when the constraining force is removed.
  • 4. The apparatus according to claim 3, wherein the apparatus further comprises a constraint, configured to provide the constraining force.
  • 5. A method for use with one or more sutures at an anatomical site of a patient, the method comprising: delivering, to a vicinity of the anatomical site, a suture-securing device that includes (1) a casing, which is shaped to define a first cutting edge, a cavity, and two openings in the casing at opposite ends of the casing, wherein the one or more sutures are disposable through the two openings and the two openings, and (2) a core, which is (a) disposed in the cavity, and (b) shaped to define a second cutting edge and a lumen, wherein the one or more sutures are disposable in the lumen;sliding the suture-securing device over at least part of the one or more sutures while the suture-securing device is in an unlocked configuration in which the one or more sutures are slidable through the two openings and the lumen; andsubsequently, by moving the suture-securing device into a locking configuration, simultaneously (1) inhibiting the one or more sutures from sliding through the lumen by fixedly coupling the suture-securing device to the one or more sutures at a coupling site of the suture-securing device, and (2) cutting entirely through the one or more sutures at a cutting site of the suture-securing device by pushing the one or more sutures against the first and the second cutting edges, such that the suture-securing device is suspended along the one or more sutures in the locking configuration with the opposite ends of the casing disposed entirely within a body of the patient.
  • 6. The method according to claim 5, wherein the suture-securing device is configured to be constrained in the unlocked configuration by a constraining force, and wherein moving the suture-securing device into the locking configuration comprises removing the constraining force.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. application Ser. No. 14/584,286, filed Dec. 29, 2014, now abandoned, which is a divisional of U.S. application Ser. No. 13/485,145, filed May 31, 2012, now U.S. Pat. No. 8,961,594.

US Referenced Citations (464)
Number Name Date Kind
4200107 Reid Apr 1980 A
4214349 Munch Jul 1980 A
4288891 Boden Sep 1981 A
4405313 Sisley et al. Sep 1983 A
4423525 Vallana et al. Jan 1984 A
4444207 Robicsek Apr 1984 A
4493329 Crawford et al. Jan 1985 A
4532926 O'Holla Aug 1985 A
4548202 Duncan Oct 1985 A
4625727 Leiboff Dec 1986 A
4675948 Bengtsson Jun 1987 A
4712549 Peters et al. Dec 1987 A
4741336 Failla et al. May 1988 A
4778468 Hunt et al. Oct 1988 A
4808157 Coombs Feb 1989 A
4853986 Allen Aug 1989 A
4878269 Anscher Nov 1989 A
5108420 Marks Apr 1992 A
5323514 Masuda Jun 1994 A
5330521 Cohen Jul 1994 A
5336233 Chen Aug 1994 A
5350399 Erlebacher et al. Sep 1994 A
5450860 O'Connor Sep 1995 A
5473812 Morris et al. Dec 1995 A
5643289 Sauer Jul 1997 A
5776178 Pohndorf et al. Jul 1998 A
5792400 Talja et al. Aug 1998 A
5843120 Israel et al. Dec 1998 A
5843164 Frantzen et al. Dec 1998 A
5904697 Gifford, III et al. May 1999 A
5948000 Larsen et al. Sep 1999 A
5957953 DiPoto et al. Sep 1999 A
6010113 Rotering Jan 2000 A
6027523 Schmieding Feb 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6193734 Bolduc et al. Feb 2001 B1
6206913 Yencho et al. Mar 2001 B1
6231516 Keilman et al. May 2001 B1
6298272 Peterfeso et al. Oct 2001 B1
6299635 Frantzen Oct 2001 B1
6332893 Mortier et al. Dec 2001 B1
6402780 Williamson, IV et al. Jun 2002 B2
6461336 Larre et al. Oct 2002 B1
6533610 Hankh et al. Mar 2003 B1
6575976 Grafton Jun 2003 B2
6602288 Cosgrove et al. Aug 2003 B1
6613078 Barone Sep 2003 B1
6613079 Wolinsky et al. Sep 2003 B1
6616684 Vidlund et al. Sep 2003 B1
6626899 Houser et al. Sep 2003 B2
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6629921 Schweich, Jr. et al. Oct 2003 B1
6641597 Burkhart et al. Nov 2003 B2
6702846 Mikus et al. Mar 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6730118 Spenser et al. May 2004 B2
6743198 Tihon Jun 2004 B1
6746472 Frazier et al. Jun 2004 B2
6776754 Wilk Aug 2004 B1
6797001 Mathis et al. Sep 2004 B2
6884250 Monassevitch et al. Apr 2005 B2
6908478 Alferness et al. Jun 2005 B2
6929660 Ainsworth et al. Aug 2005 B1
7018406 Seguin et al. Mar 2006 B2
7018408 Bailey et al. Mar 2006 B2
7037290 Gardeski et al. May 2006 B2
7041097 Webler May 2006 B1
7063711 Loshakove et al. Jun 2006 B1
7077861 Spence Jul 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7101396 Artof et al. Sep 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7144363 Pai et al. Dec 2006 B2
7159593 McCarthy et al. Jan 2007 B2
7166127 Spence et al. Jan 2007 B2
7169187 Datta et al. Jan 2007 B2
7175625 Culbert Feb 2007 B2
7179282 Alferness et al. Feb 2007 B2
7186262 Saadat Mar 2007 B2
7189199 McCarthy et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7211107 Bruckheimer et al. May 2007 B2
7258697 Cox et al. Aug 2007 B1
7311697 Osborne Dec 2007 B2
7311728 Solem et al. Dec 2007 B2
7316706 Bloom et al. Jan 2008 B2
7316710 Cheng et al. Jan 2008 B1
7329279 Haug et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7338506 Caro Mar 2008 B2
7351256 Hojeibane et al. Apr 2008 B2
7371244 Chatlynne et al. May 2008 B2
7374573 Gabbay May 2008 B2
7390329 Westra et al. Jun 2008 B2
7485143 Webler et al. Feb 2009 B2
7500989 Solem et al. Mar 2009 B2
7503931 Kowaisky et al. Mar 2009 B2
7510575 Spenser et al. Mar 2009 B2
7530995 Quijano et al. May 2009 B2
7547321 Silvestri et al. Jun 2009 B2
7549983 Roue et al. Jun 2009 B2
7597703 Sater Oct 2009 B2
7608102 Adams et al. Oct 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7628797 Tieu et al. Dec 2009 B2
7632303 Stalker et al. Dec 2009 B1
7666204 Thornton et al. Feb 2010 B2
7758632 Hojeibane et al. Jul 2010 B2
7771467 Svensson Aug 2010 B2
7780726 Seguin Aug 2010 B2
7803187 Hauser Sep 2010 B2
7837727 Goetz et al. Nov 2010 B2
7857846 Alferness et al. Dec 2010 B2
7871433 Lattouf Jan 2011 B2
7942927 Kaye et al. May 2011 B2
7972378 Tabor et al. Jul 2011 B2
7991484 Sengupta et al. Aug 2011 B1
7992567 Hirotsuka et al. Aug 2011 B2
7993368 Gambale et al. Aug 2011 B2
8010207 Smits et al. Aug 2011 B2
8025495 Hardert et al. Sep 2011 B2
8029518 Goldfarb et al. Oct 2011 B2
8052592 Goldfarb et al. Nov 2011 B2
8092525 Eliasen et al. Jan 2012 B2
8108054 Helland Jan 2012 B2
8109996 Stacchino et al. Feb 2012 B2
8137381 Foerster et al. Mar 2012 B2
8142493 Spence et al. Mar 2012 B2
8142495 Hasenkam et al. Mar 2012 B2
8147542 Maisano et al. Apr 2012 B2
8157810 Case et al. Apr 2012 B2
8172898 Alferness et al. May 2012 B2
8197441 Webler et al. Jun 2012 B2
8216302 Wilson et al. Jul 2012 B2
8226666 Zarbatany Jul 2012 B2
8236013 Chu Aug 2012 B2
8262567 Sharp et al. Sep 2012 B2
8262724 Seguin et al. Sep 2012 B2
8262725 Subramanian Sep 2012 B2
8267981 Boock et al. Sep 2012 B2
8323335 Rowe et al. Dec 2012 B2
8332051 Sommer et al. Dec 2012 B2
8398672 Kleshinski et al. Mar 2013 B2
8449606 Ellasen et al. May 2013 B2
8475525 Maisano et al. Jul 2013 B2
8480730 Maurer et al. Jul 2013 B2
8523881 Cabiri et al. Sep 2013 B2
8545553 Zipory et al. Oct 2013 B2
8628569 Benichou et al. Jan 2014 B2
8628571 Hacohen et al. Jan 2014 B1
8721588 Echarri et al. May 2014 B2
8747463 Fogarty et al. Jun 2014 B2
8784481 Alkhatib et al. Jul 2014 B2
8790394 Miller et al. Jul 2014 B2
8795356 Quadri et al. Aug 2014 B2
8808366 Braido et al. Aug 2014 B2
8852272 Gross et al. Oct 2014 B2
8858623 Miller et al. Oct 2014 B2
8870949 Rowe Oct 2014 B2
8870950 Hacohen Oct 2014 B2
8961594 Maisano et al. Feb 2015 B2
8961595 Alkhatib Feb 2015 B2
8961596 Maisano et al. Feb 2015 B2
8979922 Jayasinghe et al. Mar 2015 B2
9005273 Salahieh et al. Apr 2015 B2
9017296 Beck Apr 2015 B2
9034032 McLean et al. May 2015 B2
9034033 McLean et al. May 2015 B2
9241702 Maisano et al. Jan 2016 B2
9326870 Berglund et al. May 2016 B2
20020013571 Goldfarb et al. Jan 2002 A1
20020032481 Gabbay Mar 2002 A1
20020082625 Huxel et al. Jun 2002 A1
20020107564 Cox et al. Aug 2002 A1
20020151961 Lashinski et al. Oct 2002 A1
20020156517 Perouse Oct 2002 A1
20020177904 Huxel et al. Nov 2002 A1
20030033003 Harrison et al. Feb 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030083742 Spence et al. May 2003 A1
20030093096 McGuckin, Jr. et al. May 2003 A1
20030167071 Martin et al. Sep 2003 A1
20030229350 Kay Dec 2003 A1
20030229361 Jackson Dec 2003 A1
20030236568 Hojelbane et al. Dec 2003 A1
20040117009 Cali et al. Jun 2004 A1
20040133274 Webler et al. Jul 2004 A1
20040181287 Gellman Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193092 Deal Sep 2004 A1
20040236419 Milo Nov 2004 A1
20040260389 Case et al. Dec 2004 A1
20050004668 Aklog et al. Jan 2005 A1
20050016560 Voughlohn Jan 2005 A1
20050021085 Abrams et al. Jan 2005 A1
20050055089 Macoviak et al. Mar 2005 A1
20050059997 Bauman et al. Mar 2005 A1
20050075723 Schroeder et al. Apr 2005 A1
20050080483 Solem et al. Apr 2005 A1
20050090827 Gedebou Apr 2005 A1
20050096666 Gordon et al. May 2005 A1
20050107812 Starksen et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050113900 Shiroff et al. May 2005 A1
20050125077 Harmon et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050154448 Cully et al. Jul 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050203606 VanCamp Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050222666 Aranyi Oct 2005 A1
20050251208 Elmer et al. Nov 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050273138 To et al. Dec 2005 A1
20050283246 Cauthen, III et al. Dec 2005 A1
20060004442 Spenser et al. Jan 2006 A1
20060020326 Bolduc et al. Jan 2006 A9
20060020327 Lashinski et al. Jan 2006 A1
20060052821 Abbott et al. Mar 2006 A1
20060106420 Dolan et al. May 2006 A1
20060106423 Weisel et al. May 2006 A1
20060129166 Lavelle Jun 2006 A1
20060161265 Levine et al. Jul 2006 A1
20060173524 Salahieh et al. Aug 2006 A1
20060178700 Quinn Aug 2006 A1
20060200199 Bonutti et al. Sep 2006 A1
20060206201 Garcia et al. Sep 2006 A1
20060229708 Powell et al. Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060241748 Lee et al. Oct 2006 A1
20060259044 Onuki Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060276871 Lamson et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20070005081 Findlay, III Jan 2007 A1
20070010829 Nobles Jan 2007 A1
20070016237 Cartledge et al. Jan 2007 A1
20070016268 Gurskis et al. Jan 2007 A1
20070021781 Jervis Jan 2007 A1
20070032787 Hassett et al. Feb 2007 A1
20070038221 Fine et al. Feb 2007 A1
20070038296 Navia et al. Feb 2007 A1
20070049942 Hindrichs et al. Mar 2007 A1
20070049970 Belef et al. Mar 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070055340 Pryor Mar 2007 A1
20070060895 Sibbitt, Jr. et al. Mar 2007 A1
20070060989 Deem et al. Mar 2007 A1
20070061010 Hauser et al. Mar 2007 A1
20070066863 Rafiee et al. Mar 2007 A1
20070083168 Whiting et al. Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070100427 Perouse May 2007 A1
20070112425 Schaller et al. May 2007 A1
20070118151 Davidson May 2007 A1
20070123936 Goldin et al. May 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070168013 Douglas Jul 2007 A1
20070179530 Tieu Aug 2007 A1
20070185532 Stone et al. Aug 2007 A1
20070198082 Kapadia et al. Aug 2007 A1
20070203391 Bloom et al. Aug 2007 A1
20070208389 Amundson et al. Sep 2007 A1
20070219558 Deutsch et al. Sep 2007 A1
20070250160 Rafiee Oct 2007 A1
20070265700 Eliasen et al. Nov 2007 A1
20070270943 Solem et al. Nov 2007 A1
20070276437 Call et al. Nov 2007 A1
20070282375 Hindrichs et al. Dec 2007 A1
20070282429 Hauser et al. Dec 2007 A1
20070288089 Gurskis et al. Dec 2007 A1
20080003539 Lundgren Jan 2008 A1
20080015617 Harari et al. Jan 2008 A1
20080027268 Buckner et al. Jan 2008 A1
20080027446 Stone et al. Jan 2008 A1
20080027483 Cartledge et al. Jan 2008 A1
20080035160 Woodson et al. Feb 2008 A1
20080058866 Young et al. Mar 2008 A1
20080077231 Heringes et al. Mar 2008 A1
20080097595 Gabbay Apr 2008 A1
20080125861 Webler et al. May 2008 A1
20080140116 Bonutti Jun 2008 A1
20080167714 St. Goar et al. Jul 2008 A1
20080190989 Crews et al. Aug 2008 A1
20080234729 Page Sep 2008 A1
20080262598 Elmaleh Oct 2008 A1
20080262609 Gross et al. Oct 2008 A1
20080275469 Fanton et al. Nov 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080288044 Osborne Nov 2008 A1
20080288062 Andrieu et al. Nov 2008 A1
20080300629 Surti Dec 2008 A1
20090005792 Miyamoto Jan 2009 A1
20090005863 Goetz et al. Jan 2009 A1
20090043382 Maurer et al. Feb 2009 A1
20090048668 Wilson et al. Feb 2009 A1
20090082828 Ostroff Mar 2009 A1
20090082847 Zacharias et al. Mar 2009 A1
20090084386 McClellan et al. Apr 2009 A1
20090094798 Yao Apr 2009 A1
20090099647 Glimsdale et al. Apr 2009 A1
20090099649 Chobotov et al. Apr 2009 A1
20090112052 Lund et al. Apr 2009 A1
20090118776 Kelsch et al. May 2009 A1
20090131849 Maurer et al. May 2009 A1
20090132033 Maurer et al. May 2009 A1
20090143808 Houser Jun 2009 A1
20090149872 Gross et al. Jun 2009 A1
20090171439 Nissl Jul 2009 A1
20090216265 DeVries et al. Aug 2009 A1
20090240326 Wilson et al. Sep 2009 A1
20090254103 Deutsch Oct 2009 A1
20090259307 Gross et al. Oct 2009 A1
20090264991 Paul, Jr. et al. Oct 2009 A1
20090264995 Subramanian Oct 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20090287304 Dahlgren et al. Nov 2009 A1
20090326648 Machold et al. Dec 2009 A1
20100022948 Wilson et al. Jan 2010 A1
20100023117 Yoganathan et al. Jan 2010 A1
20100023118 Medlock et al. Jan 2010 A1
20100029071 Russell et al. Feb 2010 A1
20100030329 Frater Feb 2010 A1
20100049293 Zukowski et al. Feb 2010 A1
20100063520 Bilotti Mar 2010 A1
20100063542 van der Burg et al. Mar 2010 A1
20100063586 Hasenkam et al. Mar 2010 A1
20100121349 Meier et al. May 2010 A1
20100121434 Paul et al. May 2010 A1
20100121435 Subramanian et al. May 2010 A1
20100130992 Machold et al. May 2010 A1
20100161041 Maisano et al. Jun 2010 A1
20100161042 Maisano et al. Jun 2010 A1
20100161043 Maisano et al. Jun 2010 A1
20100161047 Cabiri Jun 2010 A1
20100168791 Kassab et al. Jul 2010 A1
20100174358 Rabkin et al. Jul 2010 A1
20100185278 Schankereli Jul 2010 A1
20100204662 Orlov et al. Aug 2010 A1
20100211166 Miller et al. Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100228269 Garrison et al. Sep 2010 A1
20100234935 Bashiri et al. Sep 2010 A1
20100249908 Chau et al. Sep 2010 A1
20100264192 Marczyk Oct 2010 A1
20100268204 Tieu et al. Oct 2010 A1
20100280603 Maisano et al. Nov 2010 A1
20100280604 Zipory et al. Nov 2010 A1
20100280605 Hammer et al. Nov 2010 A1
20100286628 Gross Nov 2010 A1
20100286767 Zipory et al. Nov 2010 A1
20100298930 Orlov Nov 2010 A1
20100324598 Anderson Dec 2010 A1
20100324668 Maurer et al. Dec 2010 A1
20110004296 Lutter et al. Jan 2011 A1
20110009818 Goff Jan 2011 A1
20110011917 Loulmet Jan 2011 A1
20110022164 Quinn et al. Jan 2011 A1
20110029066 Gilad et al. Feb 2011 A1
20110029071 Ziotnick et al. Feb 2011 A1
20110035000 Nieminen et al. Feb 2011 A1
20110040366 Goetz et al. Feb 2011 A1
20110071626 Wright et al. Mar 2011 A1
20110077733 Solem Mar 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087146 Ryan et al. Apr 2011 A1
20110092993 Jacobs Apr 2011 A1
20110093002 Rucker et al. Apr 2011 A1
20110098732 Jacobs Apr 2011 A1
20110106245 Miller et al. May 2011 A1
20110106247 Miller et al. May 2011 A1
20110112619 Foster et al. May 2011 A1
20110112632 Chau et al. May 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110152889 Ashland Jun 2011 A1
20110152998 Berez et al. Jun 2011 A1
20110166636 Rowe Jul 2011 A1
20110184510 Maisano et al. Jul 2011 A1
20110190879 Bobo et al. Aug 2011 A1
20110208283 Rust Aug 2011 A1
20110224785 Hacohen Sep 2011 A1
20110238088 Bolduc et al. Sep 2011 A1
20110238112 Kim et al. Sep 2011 A1
20110251641 Sauer Oct 2011 A1
20110251678 Eidenschink et al. Oct 2011 A1
20110264208 Duffy et al. Oct 2011 A1
20110301698 Miller et al. Dec 2011 A1
20120016343 Gill Jan 2012 A1
20120022633 Olson et al. Jan 2012 A1
20120022639 Hacohen et al. Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120035712 Maisano et al. Feb 2012 A1
20120059414 Roorda Mar 2012 A1
20120083806 Goertzen Apr 2012 A1
20120123531 Tsukashima et al. May 2012 A1
20120130374 Bouduban et al. May 2012 A1
20120130421 Hafez et al. May 2012 A1
20120143320 Eliasen et al. Jun 2012 A1
20120158053 Paulos Jun 2012 A1
20120179244 Schankereli et al. Jul 2012 A1
20120215236 Matsunaga et al. Aug 2012 A1
20120222969 Osborne et al. Sep 2012 A1
20120226349 Tuval et al. Sep 2012 A1
20120232373 Hallander et al. Sep 2012 A1
20120245604 Tegzes Sep 2012 A1
20120283757 Miller et al. Nov 2012 A1
20120296349 Smith et al. Nov 2012 A1
20120310328 Olson et al. Dec 2012 A1
20130030522 Rowe et al. Jan 2013 A1
20130041459 Wilson et al. Feb 2013 A1
20130053951 Ruyra Baliarda Feb 2013 A1
20130085529 Housman Apr 2013 A1
20130096664 Goetz et al. Apr 2013 A1
20130096672 Reich et al. Apr 2013 A1
20130166017 Cartledge et al. Jun 2013 A1
20130166022 Conklin Jun 2013 A1
20130172978 Vidlund et al. Jul 2013 A1
20130231701 Voss Sep 2013 A1
20130281760 Farnan et al. Oct 2013 A1
20130296925 Chanduszko et al. Nov 2013 A1
20130331930 Rowe et al. Dec 2013 A1
20140005778 Buchbinder et al. Jan 2014 A1
20140018911 Zhou et al. Jan 2014 A1
20140031928 Murphy et al. Jan 2014 A1
20140058405 Foster Feb 2014 A1
20140114390 Tobis et al. Apr 2014 A1
20140121763 Duffy et al. May 2014 A1
20140142689 De Canniere et al. May 2014 A1
20140163690 White Jun 2014 A1
20140200657 Maurer et al. Jul 2014 A1
20140207231 Hacohen et al. Jul 2014 A1
20140214159 Vidlund et al. Jul 2014 A1
20140243894 Groothuis et al. Aug 2014 A1
20140257475 Gross et al. Sep 2014 A1
20140288639 Gainor Sep 2014 A1
20140296962 Cartledge et al. Oct 2014 A1
20140309730 Alon et al. Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140358224 Tegels et al. Dec 2014 A1
20140379006 Sutherland et al. Dec 2014 A1
20140379074 Spence et al. Dec 2014 A1
20140379076 Vidlund et al. Dec 2014 A1
20150018940 Quill et al. Jan 2015 A1
20150045879 Longoria et al. Feb 2015 A1
20150051698 Ruyra Baliarda et al. Feb 2015 A1
20150073545 Braido Mar 2015 A1
20150094800 Chawla Apr 2015 A1
20150094802 Buchbinder et al. Apr 2015 A1
20150100116 Mohl et al. Apr 2015 A1
20150119936 Gilmore et al. Apr 2015 A1
20150127097 Neumann et al. May 2015 A1
20150142103 Vidlund May 2015 A1
20150182336 Zipory et al. Jul 2015 A1
20150223934 Vidlund et al. Aug 2015 A1
20150250590 Gries et al. Sep 2015 A1
20150272730 Melnick et al. Oct 2015 A1
20160242762 Gilmore et al. Aug 2016 A1
20160262741 Gilmore et al. Sep 2016 A1
Foreign Referenced Citations (39)
Number Date Country
102007043830 Apr 2009 DE
1568326 Aug 2005 EP
1759663 Mar 2007 EP
1836971 Sep 2007 EP
1968491 Sep 2008 EP
9205093 Apr 1992 WO
9741778 Nov 1997 WO
0028923 May 2000 WO
0110306 Feb 2001 WO
2004069055 Aug 2004 WO
2004082538 Sep 2004 WO
2005012063 Mar 2005 WO
2005102194 Nov 2005 WO
2006097931 Sep 2006 WO
2007080595 Jul 2007 WO
2009039400 Mar 2009 WO
2009101617 Aug 2009 WO
2010004546 Jan 2010 WO
2010008549 Jan 2010 WO
2010071494 Jun 2010 WO
2010073246 Jul 2010 WO
2010128502 Nov 2010 WO
2010128503 Nov 2010 WO
2011051942 May 2011 WO
2011089601 Jul 2011 WO
2011143263 Nov 2011 WO
2012127309 Sep 2012 WO
2013003228 Jan 2013 WO
2013011502 Jan 2013 WO
2013028145 Feb 2013 WO
2013078497 Jun 2013 WO
2014064694 May 2014 WO
2014087402 Jun 2014 WO
2014108903 Jul 2014 WO
2014141239 Sep 2014 WO
2015015497 Feb 2015 WO
2015063580 May 2015 WO
2015193728 Dec 2015 WO
2016087934 Jun 2016 WO
Non-Patent Literature Citations (56)
Entry
Shikhar Agarwal, et al; “Interventional Cardiology Perspective of Functional Tricuspid Regurgitation”, Circulation Cardiovascular Interventions, vol. 2, Issue 6, pp. 565-573, Dec. 2009.
Ottavio Alfieri, et al; “An Effective Technique to Correct Anterior Mitral Leaflet Prolapse”, Journal of Cardiac Surgery, vol. 14, Pt. 6, pp. 468-470; Nov.-Dec. 1999.
Ottavio Alfieri, et al, “The double-orifice technique in mitral valve repair: A simple solution for complex problems”, The Journal of Thoracic and Cardiovascular Surgery, vol. 122, pp. 674-681; Oct. 2001.
Ottavio Alfieri, et al; “Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann. Thorac Surg; vol. 74; pp. 1488-1493; Nov. 2002.
Amplatzer; Cardiac Plug Brochure (English Pages), AGA Medical Corporation, Plymouth, MN Copyright 2008-2011, downloaded Jan. 11, 2011.
Brian S. Beale; “Surgical Repair of Collateral Ligament Injuries”, presented at the 63rd CVMA Convention, Halifax, Nova Scotia, Canada, Jul. 6-9, 2011, 4 pages.
“Spinal & Epidural Needles”, downloaded on Feb. 18, 2016 from http://www.cothon.net/Anestesi_Obstetrica/Neuroaxial_needles.html.
Dentistry Today; “Implant Direct” product information page, Jun. 1, 2011, downloaded Dec. 10, 2012 from http://dentistrytoday.com/top25implant-i/5558-implant-direct.
Francesco Maisano, et al; “The double-orifice technique as a standardized approach to treat mitral regurgitation due to severy myxomatous disease: surgical technique”, European Journal of Cardio Thoracic Surgery 17. pp. 201-205, Mar. 2000.
Smith & Nephew Minitac™T12.0 Suture Anchor Product Description, downloaded on Dec. 9, 2012 from http://global.smith-nephew.com/us/MINITAC_TI_2_SUTURE_ANCHR_3127.htm.
Extended European Search Report dated Apr. 10, 2015; Appln. No. 11734451.5-1662 / 2525741 PCT/IL2011000064.
Extended European Search Report dated May 15, 2015; Appln. No. 12814417.7-1506/ 2734157 PCT/IL2012000282.
Invitation to Pay Additional Fees; PCT/IB2014/002351 dated Apr. 20, 2015.
Invitation to Pay Additional Fees: PCT/IL2014/050027 dated Apr. 4, 2014.
Invitation to Pay Additional Fees: PCT/IB15/01196 dated Oct. 26, 2015.
Invitation to Pay Additional Fees: PCT/IB2016/000840 dated Oct. 13, 2016.
International Search Report and Written Opinon dated May 19, 2011; PCT/IL11/00064.
International Search Report and Written Opinion dated Jan. 22, 2013; PCT/IL2012000282.
International Search Report and Written Opinion dated Dec. 6, 2013; PCT/IL2013/050470.
International Search Report and Written Opinion dated Mar. 17, 2014; PCT/IL1350937.
International Search Report and Written Opinion dated Jun. 30, 2014; PCT/IL2014/050233.
International Search Report and Written Opinion dated Jun. 10, 2015; PCT/IB2014/002351.
International Search Report and Written Opinion dated May 28, 2014; PCT/IL2014/050027.
International Search Report and Written Opinion dated Jan. 8, 2016; PCT/IB15/01106.
International Search Report and Written Opinion dated Apr. 15, 2016; PCT/IB2015/002354.
First Chinese Office Action dated Jun. 23, 2016; Appln. No. 201480028044.3.
Chinese Patent Office Notice of Allowance dated Sep. 5, 2016; Appln. No. 201480028044.3.
First Chinese Office Action dated Jun. 30, 2014; Appln. No. 201180015301.6.
Second Chinese Office Action dated Feb. 10, 2015; Appln. No. 201180015301.6.
Third Chinese Office Action dated Jun. 30, 2015; Appln. No. 201180015301.6.
Japanese Office Action dated Oct. 28, 2014; Appln. No. 2012-549463.
Japanese Office Action dated Jul. 7, 2015; Appln. No. 2012-549463.
USPTO NFOA dated Jul. 6, 2012 in connection with U.S. Appl. No. 12/692,061.
USPTO Interview Summary dated Nov. 5, 2012 in connection with U.S. Appl. No. 12/692,061.
USPTO NOA dated Mar. 6, 2013 in connection with U.S. Appl. No. 12/692,061.
USPTO NOA dated May 10, 2013 in connection with U.S. Appl. No. 12/692,061.
USPTO NOA dated Dec. 4, 2014 in connection with U.S. Appl. No. 13/188,175.
USPTO NFOA dated Dec. 5, 2013 in connection with U.S. Appl. No. 13/485,145.
USPTO FOA dated Jul. 7, 2014 in connection with U.S. Appl. No. 13/485,145.
USPTO FOA dated Sep. 25, 2014 in connection with U.S. Appl. No. 13/485,145.
USPTO NOA dated Dec. 9, 2014 in connection with U.S. Appl. No. 13/485,145.
USPTO NFOA dated Nov. 25, 2014 in connection with U.S. Appl. No. 13/553,081.
USPTO NOA dated Sep. 14, 2015 in connection with U.S. Appl. No. 13/553,081.
USPTO RR dated Feb. 25, 2015 in connection with U.S. Appl. No. 13/574,088.
USPTO NFOA dated Oct. 7, 2015 in connection with U.S. Appl. No. 13/574,088.
USPTO FOA dated May 11, 2016 in connection with U.S. Appl. No. 13/574,088.
USPTO NFOA dated Sep. 14, 2016 in connection with U.S. Appl. No. 13/574,088.
USPTO RR dated Feb. 2, 2015 in connection with U.S. Appl. No. 14/143,355.
USPTO NOA dated Sep. 24, 2015 in connection with U.S. Appl. No. 14/143,355.
USPTO NOA dated Dec. 4, 2015 in connection with U.S. Appl. No. 14/143,355.
USPTO NFOA dated Apr. 18, 2016 in connection with U.S. Appl. No. 14/584,286.
U.S. Appl. No. 60/902,146, filed Feb. 16, 2007.
U.S. Appl. No. 62/014,397, filed Jun. 19, 2014.
U.S. Appl. No. 62/086,269, filed Dec. 2, 2014.
U.S. Appl. No. 62/167,660, filed May 28, 2015.
U.S. Appl. No. 62/131,636, filed Mar. 11, 2016.
Related Publications (1)
Number Date Country
20170000474 A1 Jan 2017 US
Divisions (1)
Number Date Country
Parent 13485145 May 2012 US
Child 14548286 US
Continuations (1)
Number Date Country
Parent 14548286 Dec 2014 US
Child 15267769 US